Event

Date:

March 26, 2018 - 12:00 AM to March 27, 2018 - 12:00 AM

Details:

FDA, NIAAA, AASLD Workshop - Clinical Trial Design and Endpoints for Alcoholic Hepatitis and other Alcohol-Associated Liver Diseases 

Purpose: The purpose of this workshop is to address challenges related to clinical trial designs and drug development in Alcoholic Associated Liver Disease (AALD) and Alcoholic Hepatitis (AH) including populations to study, endpoints, and diagnostic criteria. For details visit https://niaaa.nih.gov/alcoholic-hepatitis-workshop-fda-niaaa-aasld

Registration information: 
https://niaaa.nih.gov/alcoholic-hepatitis-workshop-fda-niaaa-aasld-registration


Agenda:
https://niaaa.nih.gov/alcoholic-hepatitis-workshop-fda-niaaa-aasld-agenda

Alcoholic Hepatitis Workshop FDA, NIAAA, AASLD Clinical Trial Endpoints for AH

Location:

Food and Drug Administration
Great Room – White Oak Campus
10903 New Hampshire Ave.,
Silver Spring, MD